Author(s): Kurup P, Reddy S, Hendrickson FR
After an initial course of radiation, 56 patients with cerebral metastases had their brain retreated at least once for recurrent neurologic symptoms. The most common primary was from either the lung or breast. The frequent symptoms were headache, weakness, seizures, visual problems, and/or mental changes. Forty-two (75%) of these patients responded to the second course of treatment. The median duration of response was 10 weeks and median survival was 14 weeks.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/7448697
Author(s): Gavrilovic IT, Posner JB
Author(s): Delattre JY, Krol G, Thaler HT, Posner JB
Author(s): Wong WW, Schild SE, Sawyer TE, Shaw EG
Author(s): Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, et al.
Author(s): van den Bent MJ1
Author(s): Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, et al.
Author(s): Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, et al.
Author(s): Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, et al.
Author(s): Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, et al.
Author(s): Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, et al.
Author(s): Gaspar LE, Scott C, Murray K, Curran W
Author(s): Videtic GM, Adelstein DJ, Mekhail TM, Rice TW, Stevens GH, et al.
Author(s): Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W
Author(s): Golden DW, Lamborn KR, McDermott MW, Kunwar S, Wara WM, et al.
Author(s): Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, et al.
Author(s): Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, et al.
Author(s): Adler JR, Chang SD, Murphy MJ, Doty J, Geis P, et al.
